Privia Health Group, Inc. (NASDAQ:PRVA) Shares Purchased by KBC Group NV

KBC Group NV lifted its position in Privia Health Group, Inc. (NASDAQ:PRVA) by 34.6% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,385 shares of the company’s stock after acquiring an additional 871 shares during the quarter. KBC Group NV’s holdings in Privia Health Group were worth $62,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in PRVA. Vanguard Group Inc. boosted its holdings in Privia Health Group by 1.1% in the first quarter. Vanguard Group Inc. now owns 11,400,035 shares of the company’s stock worth $223,327,000 after purchasing an additional 121,701 shares during the period. Millennium Management LLC lifted its position in shares of Privia Health Group by 2,994.2% in the 2nd quarter. Millennium Management LLC now owns 1,138,526 shares of the company’s stock worth $19,788,000 after buying an additional 1,101,730 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of Privia Health Group by 18.4% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,118,619 shares of the company’s stock valued at $19,441,000 after buying an additional 173,934 shares during the period. Sei Investments Co. grew its position in shares of Privia Health Group by 0.6% during the 2nd quarter. Sei Investments Co. now owns 460,605 shares of the company’s stock valued at $8,005,000 after buying an additional 2,725 shares during the last quarter. Finally, BlackBarn Capital Partners LP raised its stake in Privia Health Group by 100.0% during the second quarter. BlackBarn Capital Partners LP now owns 400,000 shares of the company’s stock worth $6,952,000 after acquiring an additional 200,000 shares during the period. 94.48% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research firms have recently commented on PRVA. Royal Bank of Canada reaffirmed an “outperform” rating and set a $28.00 target price on shares of Privia Health Group in a report on Wednesday, August 14th. Barclays upped their price objective on Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Friday, November 8th. Truist Financial raised their target price on Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a research note on Friday, November 8th. KeyCorp started coverage on shares of Privia Health Group in a research report on Friday, October 11th. They set an “overweight” rating and a $23.00 price target for the company. Finally, Robert W. Baird lifted their price objective on shares of Privia Health Group from $23.00 to $24.00 and gave the company an “outperform” rating in a research report on Monday, August 26th. Two equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Buy” and an average price target of $25.07.

Privia Health Group Stock Performance

Shares of NASDAQ PRVA opened at $21.56 on Friday. Privia Health Group, Inc. has a 1 year low of $15.92 and a 1 year high of $24.30. The firm has a market cap of $2.59 billion, a P/E ratio of 215.62, a PEG ratio of 5.26 and a beta of 0.76. The stock has a fifty day moving average price of $18.96 and a two-hundred day moving average price of $18.57.

Insider Activity

In related news, CEO Parth Mehrotra sold 135,142 shares of the stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $18.50, for a total transaction of $2,500,127.00. Following the completion of the sale, the chief executive officer now directly owns 247,771 shares of the company’s stock, valued at $4,583,763.50. This represents a 35.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 14.20% of the company’s stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.